SINGAPORE and SEOUL, South Korea, April 19, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences, a global clinical-stage biotech company, focused on discovering and developing novel targeted oncology...
Handok Pharmaceuticals said it obtained the US FDA approval to conduct a phase 2 clinical trial of ABL001 (CTX-009), an investigational anticancer treatment the Korean company is jointly developing with Compass Therapeutics.